Search - tctmd.com

Displaying 21 - 40 of 294

Sort: Relevancy | Date

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

PAD Patients’ Views on Decisions and Outcomes Hinge on Sex, Race/Ethnicity: ELEGANCE

L.A. McKeown

November 04, 2024

Presentation TCT 2024

TCT 331: Use of Automated Contrast Injector Versus Manifold in Cardiac Catheterization Laboratory Procedures Is Not Associated With Reduced Procedural Contrast Volumes or Rates of Acute Kidney Injury

Presenter: Ahmed Athar

October 30, 2024

Presentation TCT 2024

TCT 731: Setting the Stage: Comparative Analysis of Pulmonary Embolism Intervention in the Cath Lab Versus Operating Room

Presenter: Ahmed Kazem

October 28, 2024

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Conference News ESC 2024

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Caitlin E. Cox

September 10, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

Shelley Wood

May 31, 2024

News Daily News

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

L.A. McKeown

May 17, 2024

News Conference News SCAI 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

L.A. McKeown

May 10, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

Presentation Fellows 2024

Vascular Access and Management (Femoral, Radial, and Alternative): A Step-by-Step Approach

Presenter: Douglas E. Drachman

April 12, 2024

News Daily News

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

Yael L. Maxwell

April 03, 2024

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

L.A. McKeown

March 25, 2024

News Conference News CRT 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

L.A. McKeown

March 20, 2024

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Conference News ISC 2024

ZODIAC: Laying Flat Equals Better Outcomes for Stroke Thrombectomy Candidates

Todd Neale

February 08, 2024

Advertisement

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

PAD Patients’ Views on Decisions and Outcomes Hinge on Sex, Race/Ethnicity: ELEGANCE

TCT 331: Use of Automated Contrast Injector Versus Manifold in Cardiac Catheterization Laboratory Procedures Is Not Associated With Reduced Procedural Contrast Volumes or Rates of Acute Kidney Injury

TCT 731: Setting the Stage: Comparative Analysis of Pulmonary Embolism Intervention in the Cath Lab Versus Operating Room

October 2024 Dispatch for the CV Team

Little Pre- and Postmarket Testing for Most Recalled CV Devices

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

September 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for May 2024

AHA/ACC and Others Issue PAD Guideline Update With Focus on Collaborative Care

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

May 2024 Dispatch for the CV Team

FDA Approves Bioresorbable Scaffold for BTK Lesions

Vascular Access and Management (Femoral, Radial, and Alternative): A Step-by-Step Approach

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

Physicians (Mostly) Negative on Private Equity in Healthcare

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

ZODIAC: Laying Flat Equals Better Outcomes for Stroke Thrombectomy Candidates

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content